Tarsus Pharmaceuticals
The Associate Director, Chemical Development leads strategic planning and execution of CMC activities for drug substance development and manufacturing across CMOs from preclinical through commercialization. Reporting to the Director of Chemical Development, the role provides technical and operational leadership, collaborates with cross‑functional teams, and ensures supply continuity, regulatory compliance, and budget management.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
15% below the average for this role
Senior Scientist, Chemical Development
Alumis
Executive Director CMC/ Pharmaceutical Development
Clinical Dynamix
Senior Scientist
Merck & Co., Inc.
Associate Director CMC, Drug Substance
Latigobio
Sr. Director, ADC Drug-Linker Synthetic Process Development
Eli Lilly and Company
Senior Director, Drug Substance Development
altimmune